1. Natriureticus peptidek mérése szívelégtelen betegekben: a helyes laboratóriumi és klinikai gyakorlat
- Author
-
Róbert Sepp, L. Gábor Kovács, Agota Hajas, János Tomcsányi, János Kappelmayer, Zsolt Piroth, Béla Merkely, Noémi Nyolczas, Tamas Habon, and Imre Boncz
- Subjects
Patient discharge ,medicine.medical_specialty ,business.industry ,medicine.drug_class ,Treatment outcome ,Cardiovascular homeostasis ,General Medicine ,Health economy ,Orvostudományok ,medicine.disease ,Natriuresis ,Heart failure ,Severity of illness ,medicine ,Natriuretic peptide ,Elméleti orvostudományok ,Intensive care medicine ,business - Abstract
Cardiac natriuretic peptides (BNP, NT-proBNP) play a pivotal role in cardiovascular homeostasis, mainly due to their roles in vasodilatation, natriuresis, diuresis and due to their antiproliferative properties. Proper measurement of the natriuretic peptide levels may help differentiate between respiratory and cardiac forms of dyspnea, diagnose early forms of heart failure, evaluate severity of heart failure (prognosis) and monitor the efficacy of therapy. In many countries natriuretic peptide levels are being used as one of the earliest diagnostics tools to evaluate the involvement of the heart. Current theoretical and clinical data confirm the importance of natriuretic peptides in routine healthcare. These roles are clearly described in international recommendations and guidelines. In the current review the authors discuss the problems of the measurement of natriuretic peptides in Hungary, including several aspects related to laboratory medicine, cardiology and health economy. Orv. Hetil., 2015, 156(31), 1235–1245.
- Published
- 2015